A detailed history of Ropes Wealth Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ropes Wealth Advisors LLC holds 4,645 shares of LLY stock, worth $3.7 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
4,645
Previous 5,381 13.68%
Holding current value
$3.7 Million
Previous $2.52 Million 1.15%
% of portfolio
0.49%
Previous 0.42%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 19, 2023

SELL
$434.7 - $599.3 $319,939 - $441,084
-736 Reduced 13.68%
4,645 $2.49 Million
Q2 2023

Aug 07, 2023

BUY
$350.74 - $468.98 $90,140 - $120,527
257 Added 5.02%
5,381 $2.52 Million
Q1 2023

May 08, 2023

BUY
$310.63 - $364.82 $210,607 - $247,347
678 Added 15.25%
5,124 $1.76 Million
Q4 2022

Feb 06, 2023

BUY
$321.55 - $374.67 $193,573 - $225,551
602 Added 15.66%
4,446 $1.63 Million
Q3 2022

Nov 01, 2022

SELL
$296.48 - $337.87 $32,316 - $36,827
-109 Reduced 2.76%
3,844 $1.24 Million
Q2 2022

Aug 10, 2022

SELL
$278.73 - $327.27 $43,760 - $51,381
-157 Reduced 3.82%
3,953 $1.28 Million
Q1 2022

May 04, 2022

SELL
$234.69 - $291.66 $200,190 - $248,785
-853 Reduced 17.19%
4,110 $1.18 Million
Q4 2021

Feb 10, 2022

SELL
$224.85 - $279.04 $2,473 - $3,069
-11 Reduced 0.22%
4,963 $1.37 Million
Q3 2021

Nov 05, 2021

SELL
$221.6 - $272.71 $114,567 - $140,991
-517 Reduced 9.42%
4,974 $1.15 Million
Q2 2021

Aug 04, 2021

BUY
$180.55 - $233.54 $110,857 - $143,393
614 Added 12.59%
5,491 $1.26 Million
Q1 2021

May 12, 2021

BUY
$164.32 - $212.72 $64,249 - $83,173
391 Added 8.72%
4,877 $950,000
Q4 2020

Feb 05, 2021

SELL
$130.46 - $172.63 $28,309 - $37,460
-217 Reduced 4.61%
4,486 $757,000
Q3 2020

Oct 16, 2020

SELL
$146.22 - $169.13 $19,885 - $23,001
-136 Reduced 2.81%
4,703 $696,000
Q2 2020

Jul 20, 2020

SELL
$136.42 - $164.18 $5,047 - $6,074
-37 Reduced 0.76%
4,839 $794,000
Q1 2020

Apr 24, 2020

SELL
$119.05 - $147.35 $30,953 - $38,311
-260 Reduced 5.06%
4,876 $676,000
Q3 2019

Nov 05, 2019

SELL
$106.79 - $116.16 $1,601 - $1,742
-15 Reduced 0.29%
5,136 $574,000
Q2 2019

Jul 31, 2019

SELL
$110.79 - $129.32 $1,661 - $1,939
-15 Reduced 0.29%
5,151 $571,000
Q1 2019

Apr 15, 2019

SELL
$111.31 - $131.02 $19,034 - $22,404
-171 Reduced 3.2%
5,166 $670,000
Q4 2018

Feb 08, 2019

SELL
$105.9 - $118.64 $25,310 - $28,354
-239 Reduced 4.29%
5,337 $618,000
Q3 2017

Nov 09, 2017

BUY
$77.07 - $85.54 $429,742 - $476,971
5,576
5,576 $477,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ropes Wealth Advisors LLC Portfolio

Follow Ropes Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ropes Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ropes Wealth Advisors LLC with notifications on news.